Department of Pharmacotherapy and Translational Research, College of Pharmacy, PO Box 100486, University of Florida, Gainesville, FL 32610-0486, USA.
Nat Rev Cardiol. 2011 Jan;8(1):42-9. doi: 10.1038/nrcardio.2010.182. Epub 2010 Nov 16.
Hypertension and diabetes mellitus frequently occur together, leading to increased complications and mortality in patients with both these conditions. Blood pressure (BP) goals for patients with diabetes have consistently been more aggressive than for patients without diabetes. Although the benefits of lowering BP are well documented, data to support this more aggressive goal are lacking. In fact, lowering BP might not always be better. We review the available evidence regarding BP treatment in patients with hypertension and diabetes from randomized clinical trials, as well as available observational data. We also consider evidence related to the J-shaped curve, which reflects the relationship between BP and outcomes in patients with diabetes, and make recommendations for treatment of BP on the basis of a patient's individual risk, as opposed to on the basis of aggressive BP targets recommended by global guidelines. In the future, a personalized approach will maximize the benefits from treatment.
高血压和糖尿病常同时发生,导致同时患有这两种疾病的患者并发症和死亡率增加。糖尿病患者的血压(BP)目标一直比没有糖尿病的患者更积极。尽管降低 BP 的益处已有充分的记录,但缺乏支持这一更积极目标的数据。事实上,降低 BP 并不总是更好。我们从随机临床试验以及现有的观察数据中回顾了高血压和糖尿病患者 BP 治疗的现有证据。我们还考虑了与 J 形曲线相关的证据,该曲线反映了糖尿病患者 BP 与结局之间的关系,并根据患者的个体风险而非全球指南推荐的积极 BP 目标为治疗 BP 提出建议。未来,个性化方法将最大限度地提高治疗效果。